Search

everythinglearnresearchcommunity

for

Search:↓

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Most postmenopausal women experience significant skin changes and various skin conditions.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

GnRH treatment can reduce breast cancer cell invasion.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Testosterone therapy may help women with low sexual desire after surgical menopause.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Some breast cancer chemotherapy can cause permanent hair loss.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Early baldness and little chest hair may indicate higher prostate cancer risk.